The study is designed to compare the efficacy and safety of cyclosporine versus placebo , in addition to revascularization by PPCI , in patients presenting with acute anterior myocardial infarction within 12 hours of symptoms onset and initial TIMI flow 1 in the culprit left anterior descending coronary artery .